Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03400787Not ApplicableCompleted

Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse

Role: lead

NCT02964312Not ApplicableCompleted

LATERA-OFFICE Study

Role: lead

NCT02952313Not ApplicableCompleted

Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study

Role: lead

NCT02188589Not ApplicableCompleted

Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse

Role: lead

All 4 trials loaded